David Schnee
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
David Schnee has a total of 19 co-authors. Here are the top co-authors by number of shared publications:
- Kathy Zaiken
Massachusetts College of Pharmacy and Health Sciences, Boston, USA
3 shared publications - Dhiren Patel
VA Boston Healthcare System Boston MA USA
2 shared publications - Amee Mistry
Associate Professor of Pharmacy Practice MCPHS University, 179 Longwood Ave Boston, MA 02115, United States
1 shared publication - Catherine A. Taglieri
Massachusetts College of Pharmacy and Health Sciences (MCPHS University), Boston, Massachusetts
1 shared publication Eli Philips
MCPHS University, Boston, Massachusetts
1 shared publicationErika Felix-Getzik
MCPHS University, Boston, Massachusetts
1 shared publication
Latest Publications
- 1 August 2019
- Published by Elsevier in American Journal of Pharmaceutical Education
- Vol. 83 (6) , 1200-1206
Effect of Live Attendance and Video Capture Viewing on Student Examination Performance
Objective. To compare pharmacy students’ performance in a therapeutics course after attending live lectures and/or viewing video-recorded lectures. Methods. Attendance was taken during seven lectures spaced equally throughout the therapeutics course. Data on students’ viewing of the video-recorded lectures was extracted. Students were grouped based on class attendance and video-viewing behavior; these data were correlated to student performance on examination lecture specific material. The data were also evaluated based on students’ final course grade. Results. From each lecture for which data were collected, between 346 and 349 students were included in the analysis, resulting in 2,430 data points. Students who were attended lecture and did not access the video-recorded lecture were associated with better performance on the respective examination than students who were absent and accessed the video-recorded lecture only once (grade=71.0 vs 62.3). Students who attended lecture, regardless of whether they subsequently viewed the video online, were associated with better performance on the examination than students who were absent (70.4 vs 64.0). Among all students who attended lecture, those that also used the video-recorded lecture were associated with similar performance on the examination as those who did not access the video (grade=69.1 vs 71.0). Conclusion. Results from this pilot study demonstrated that live class attendance was associated with higher examination performance than viewing recorded lectures for a therapeutics class. The results of this pilot study can be used to guide future research in understanding how teaching methods affect student performance.
- 1 August 2019
- Published by Elsevier in American Journal of Pharmaceutical Education
- Vol. 83 (6) , 1200-1206
Effect of Live Attendance and Video Capture Viewing on Student Examination Performance
Objective. To compare pharmacy students’ performance in a therapeutics course after attending live lectures and/or viewing video-recorded lectures. Methods. Attendance was taken during seven lectures spaced equally throughout the therapeutics course. Data on students’ viewing of the video-recorded lectures was extracted. Students were grouped based on class attendance and video-viewing behavior; these data were correlated to student performance on examination lecture specific material. The data were also evaluated based on students’ final course grade. Results. From each lecture for which data were collected, between 346 and 349 students were included in the analysis, resulting in 2,430 data points. Students who were attended lecture and did not access the video-recorded lecture were associated with better performance on the respective examination than students who were absent and accessed the video-recorded lecture only once (grade=71.0 vs 62.3). Students who attended lecture, regardless of whether they subsequently viewed the video online, were associated with better performance on the examination than students who were absent (70.4 vs 64.0). Among all students who attended lecture, those that also used the video-recorded lecture were associated with similar performance on the examination as those who did not access the video (grade=69.1 vs 71.0). Conclusion. Results from this pilot study demonstrated that live class attendance was associated with higher examination performance than viewing recorded lectures for a therapeutics class. The results of this pilot study can be used to guide future research in understanding how teaching methods affect student performance.
- 1 May 2017
- Published by Elsevier in Currents in Pharmacy Teaching and Learning
- Vol. 9 (3) , 391-397
Comparison of long-term knowledge retention in lecture-based versus flipped team-based learning course delivery
- 1 May 2017
- Published by Elsevier in Currents in Pharmacy Teaching and Learning
- Vol. 9 (3) , 391-397
Comparison of long-term knowledge retention in lecture-based versus flipped team-based learning course delivery
- Open Access
- 15 July 2013
- Published by Springer Nature in Journal of Medical Case Reports
- Vol. 7 (1) , 183
Angiotensin II type 1 receptor blocker-induced immune thrombocytopenia: a case report
The development of thrombocytopenia after a dose increase in losartan and subsequently after switching the patient to valsartan is reported.
- 15 July 2013
- Published by Springer Nature in Journal of Medical Case Reports
- Vol. 7 (1) , 183
Open AccessAngiotensin II type 1 receptor blocker-induced immune thrombocytopenia: a case report
The development of thrombocytopenia after a dose increase in losartan and subsequently after switching the patient to valsartan is reported.
- 1 May 2007
- Vol. 20 (5) , 53-7
An evaluation of low-dose simvastatin in achieving LDL goal: a retrospective chart review.
Treatment for hyperciholesterolemia targets low-density lipoprotein (LDL) cholesterol. In July 2004, an update to the existingcholesterol guidelines was published that recommended more intense lowering of LDL levels. This study, a retrospective chart review conducted at a multispecialty medical group practice, aimed to determine iflow-dose simvastatin (5 or 10 mg) was effective at achieving LDL goal, in light of these more aggressive guidelines. Demographic data, including risk factors and LDL levels, were collected on 173 patients identified as taking low-dose simvastatin. The review indicated that 66% of patients with low-to-rnoderate cardiovascular risk treated with low-dose simvastatin achieved their risk-appropriate LDL goalMore than 50% of patients who achieved this LDL goal on low-dose simvastatin fell into lower-risk cattegories. Therefore, low-dose simvastatin may be a beneficial treatment option for patients in lower cardiovascular-risk categories.
- 1 May 2007
- Vol. 20 (5) , 53-7
An evaluation of low-dose simvastatin in achieving LDL goal: a retrospective chart review.
Treatment for hyperciholesterolemia targets low-density lipoprotein (LDL) cholesterol. In July 2004, an update to the existingcholesterol guidelines was published that recommended more intense lowering of LDL levels. This study, a retrospective chart review conducted at a multispecialty medical group practice, aimed to determine iflow-dose simvastatin (5 or 10 mg) was effective at achieving LDL goal, in light of these more aggressive guidelines. Demographic data, including risk factors and LDL levels, were collected on 173 patients identified as taking low-dose simvastatin. The review indicated that 66% of patients with low-to-rnoderate cardiovascular risk treated with low-dose simvastatin achieved their risk-appropriate LDL goalMore than 50% of patients who achieved this LDL goal on low-dose simvastatin fell into lower-risk cattegories. Therefore, low-dose simvastatin may be a beneficial treatment option for patients in lower cardiovascular-risk categories.
- 1 January 2006
- Published by Informa Healthcare in Current Medical Research and Opinion
An update on the pharmacological treatment of obesity
- 1 January 2006
- Published by Informa Healthcare in Current Medical Research and Opinion
An update on the pharmacological treatment of obesity